Study: Removing ovaries before age 50 may increase the risk of chronic conditions for some women
Removal of ovaries and fallopian tubes prevents ovarian cancer, but it may come with other health risks. Experts recommend removal of ovaries and fallopian tubes in women at high risk for ovarian cancer due to inherited mutations in BRCA or other genes linked to ovarian cancer risk. For these high-risk women the benefit of ovarian cancer prevention outweighs the risk of long-term complications. Based on a recent study, some researchers feel that for women who are not at increased risk for cancer, the risk for some chronic conditions is too high to consider removal of both ovaries. (11/1/16)
Most relevant for: Women under 50 years of age who have had or are considering removing their ovaries.
It may also be relevant for:
- previvors
- people with a genetic mutation linked to cancer risk
- people with a genetic mutation linked to cancer risk
- people with breast cancer
Relevance: Medium
Strength of Science: Medium-High
Who covered this study?
Science Daily
Ovarian removal to prevent ovarian cancer should not be an option for premenopausal women, research finds
This article rates
3.0 out of 5 stars
Ovarian Cancer News Today
Preventative ovary removal in premenopausal women should be discontinued, researchers warn
This article rates
3.0 out of 5 stars
Contents
| At a glance | In-depth |
| Findings | Limitations |
| Clinical trials | Resources |
| Questions for your doctor |
STUDY AT A GLANCE
This study is about:
Whether there is a connection between women who had their ovaries removed before age 50 and an increased risk of common chronic conditions, such as depression, asthma, coronary artery disease, and .
Why is this study important?
Researchers want to better understand the risks and benefits of ovary removal before age 50. Preventing ovarian cancer is a benefit of this procedure. However, ovaries produce hormones and removing ovaries at a young age can increase the risk for other diseases. Women need to understand the benefits and risks of ovary removal in order to make informed decision about the procedure. For women with an average chance for developing ovarian cancer, the risks that result from losing these sex hormones may not outweigh the benefit.
Study findings:
- Women who had their ovaries removed before age 46 were at increased risk of depression, hyperlipidemia (high cholesterol and/or triglycerides in the blood), heart disease, coronary artery disease, arthritis, lung issues such as asthma and chronic obstructive pulmonary disease, and bone loss ().
- Women who had their ovaries removed between ages 46 and 49 were at increased risk for depression, anxiety, hyperlipidemia, diabetes, arthritis, and cancer (all types).
- Women who received therapy were able to reduce some of these increased risks.
What does this mean for me?
While the results of this study suggest that having ovaries removed before age 50 may increase a woman’s risk of some chronic conditions, it is important to note that the women in this study were not at increased risk for ovarian cancer. Generally, more work needs to be done to confirm and understand these findings. Women should work with their doctors to weigh their personal risks for ovarian cancer and determine whether or not they want to remove their ovaries, and if so, at what age. Women should also speak with their healthcare team to decide if they are candidates for replacement therapy.
Women diagnosed with breast cancer before age 50 meet national guidelines for genetic counseling and testing to see if they have an that increases breast and/or ovarian cancer risk. These guidelines recommend removing the ovaries and for women who have a mutation in or . Women with mutations in , , , and the genes associated with should consider removal of their ovaries.
Posted 11/1/16
Share your thoughts on this XRAYS article by taking our brief survey.
Reference
Rocca WA, Gazzuola-Rocca, L, Smith CY, et al, “Accelerated Accumulation of Multimorbidity After Oophrectomy: A Population-Based Cohort Study.” Mayo Clinic Proceedings. Published online first in 2016.
Disclosure
FORCE receives funding from industry sponsors, including companies that manufacture cancer drugs, tests and devices. All XRAYS articles are written independently of any sponsor and are reviewed by members of our Scientific Advisory Board prior to publication to assure scientific integrity.
IN DEPTH REVIEW OF RESEARCH
Study background:
There are differing opinions on whether or not women with average (1.5%) lifetime risk of ovarian cancer should have (removal of the ovaries) before menopause. is recommended for women with a high (up to 50% lifetime risk) likelihood of developing ovarian cancer due to a mutation in , or other gene associated with increased ovarian cancer risk, because the benefit of cancer prevention far outweighs the chance of other health problems. However, some women have their ovaries removed for other reasons. For example, women undergoing hysterectomy (removal of their uterus) for other reasons will sometimes have their ovaries removed at the same time. For many years, experts debated whether women with an average risk of ovarian cancer benefit from removing their ovaries, or if the risk of other complications is too high. Previous research from the same team found that “for most women without a cancer indication, the long-term risks of oophorectomy performed before menopause are greater than the benefits.” However, others have argued more research is needed.
Walter Rocca and colleagues from Mayo Clinic published work in 2016 in the journal Mayo Clinic Proceedings that provides more data on risks of before menopause.
Researchers of this study wanted to know:
Does removing ovaries before age 50 increase a woman’s risk of common chronic conditions associated with aging?
Population(s) looked at in the study:
This study followed 1,653 women with intact ovaries and 1,653 women who had both ovaries removed before age 50 for about 14 years (some women were followed for a longer period and some for a shorter period). The oophorectomies were performed between January 1, 1988 and December 31, 2007. Study participants who had their ovaries removed did so while also having their uterus removed (hysterectomy) for reasons other than cancer treatment or managing cancer risk. Women who had their ovaries removed to help treat breast cancer or reduce their high genetic risk of cancer due to a mutation in were excluded from this study.
Study findings:
- Women who had their ovaries removed before age 46 were at increased risk of depression, hyperlipidemia (high cholesterol and/or triglycerides in the blood), heart disease, coronary artery disease, arthritis, lung issues such as asthma and chronic obstructive pulmonary disease, and bone loss ().
- Women who had their ovaries removed between ages 46 and 49 were at increased risk for depression, anxiety, hyperlipidemia, diabetes, arthritis, and cancer (all types).
- Women who received therapy were able to reduce some of these increased risks.
Limitations:
It is very important to note that this study looked only at women with an average risk for ovarian cancer; it did not include women with increased risk of ovarian cancer (such as mutation carriers) or women who had their ovaries removed to reduce their risk of breast cancer. As such, these findings do not apply to these women where the benefits likely outweigh the risks.
The study had other limitations as well. The authors acknowledge a potential underestimation of some of the conditions that they looked at because some participants may not have had symptoms or did not request medical attention. Additionally, the researchers recognize that there may be a surveillance bias—the women who had their ovaries removed may have more contact with their health care providers after their surgery. Finally, some of the women in this study had their ovaries removed about 20 years ago when the surgeries and therapies were different.
Conclusions:
This study suggests that having an before age 50 may increase a woman’s risk of some chronic conditions, including heart disease, lung disease, coronary artery disease, anxiety, and depression. There are many reasons women with breast cancer or high risk for breast cancer may consider removal of their ovaries, such as reduction of breast cancer risk, treatment for breast cancer, and reduction of ovarian cancer risk associated with inherited mutations. All women should discuss the risks and benefits of with their health care providers to determine which choice is best for them.
It is important to remember that national guidelines recommend removal of ovaries and after completion of childbearing for women with mutations in and . Women with mutations in , , , and the genes associated with are advised to consider removing their ovaries and to reduce their ovarian cancer risk. Women with inherited mutations in these genes or who are undergoing for other indications should be told of the long-term risks of ovary removal, but reminded that the benefits of preventing ovarian cancer far outweigh the risks of long-term complications.
Women at average risk of ovarian cancer should speak to their health care provider about considering risk when presented with the option to remove their ovaries.
Posted 11/1/16
Share your thoughts on this XRAYS article by taking our brief survey.
Expert Guidelines
The National Comprehensive Cancer Network (NCCN) provides guidelines for the management of gynecologic cancer risk in people with and mutations.
Prevention
- Risk-reducing removal of ovaries and , (known as risk-reducing salpingo-oophorectomy or ) is recommended between ages 35-40 for and 40-45 for and upon completion of childbearing.
- Research shows that removing the ovaries can increase survival for women with or mutations.
- Women should talk with their doctors about the effects of early menopause and options for managing them.
- Women should talk with their doctors about the risks and benefits of keeping or removing their uterus (hysterectomy), including:
- Women with a or mutation have an increased risk for a rare form of aggressive uterine cancer; hysterectomy removes this risk.
- For women considering hormone replacement after surgery, the presence or absence of a uterus can affect the choice of hormones used.
- Estrogen-only hormone replacement is less likely to increase the risk for breast cancer, although it increases the risk for uterine cancer. Women who still have their uterus are typically given hormone replacement with both and progesterone.
- Adding progesterone to hormone replacement can protect against uterine cancer. However, the combination of these hormones may increase the risk for breast cancer more than alone.
- A medical history of fibroids or other uterine or cervical issues may justify a hysterectomy.
- Oral contraceptives (birth control pills) have been shown to lower the risk for ovarian cancer in women with mutations. Research on the effect of oral contraceptives on breast cancer risk has been mixed. Women should discuss the benefits and risks of oral contraceptives for lowering ovarian cancer risk with their doctors.
- Removal of the only () is being studied as an option for lowering risk in high-risk women who are not ready to remove their ovaries. Studies on the effects of are ongoing. Whether lowers the risk for ovarian cancer in high-risk women remains unknown.
- Consider enrolling in a research study looking at this procedure to lower cancer risk.
Screening
- There are no proven benefits to routine ovarian cancer screening using transvaginal and a blood test. These tests are not currently recommended.
- After , a very small risk remains for a related cancer known as primary peritoneal cancer (PPC). There is no effective screening for PPC after
- Women should be aware of the symptoms of gynecologic cancer and report abnormalities to their doctors, particularly if they persist for several weeks and are a change from normal. These symptoms can include:
- pelvic or abdominal pain
- bloating or distended belly
- difficulty eating
- feeling full sooner than normal
- increased urination or pressure to urinate
Updated: 01/29/2025
Expert Guidelines
The National Comprehensive Cancer Network (NCCN) provides the following guidelines for the management of gynecologic cancer risk in people with inherited mutations that are linked to endometrial or ovarian cancer. We recommend that you speak with a genetics expert who can look at your personal and family history of cancer and help you to determine the best risk management plan.
, or mutation
- Recommend risk-reducing salpingo-oophorectomy between the ages of 45-50.
- Be aware of endometrial and ovarian cancer symptoms.
- Consider endometrial biopsy every 1-2 years beginning at ages 30-35.
- For postmenopausal women, consider transvaginal after discussion with your doctor.
- Consider risk-reducing hysterectomy; discuss risk-reducing removal of ovaries and with your doctor (, , and ).
- Discuss the benefits and risks of oral contraceptives.
mutation
- Be aware of endometrial cancer symptoms.
- Consider endometrial biopsy every 1-2 years beginning at age 35.
- For postmenopausal women, consider transvaginal after a discussion with your doctor.
- Consider risk-reducing hysterectomy.
Updated: 02/23/2023
Expert Guidelines
The National Comprehensive Cancer Network (NCCN) has cancer risk management guidelines for people with inherited mutations linked to cancer. The NCCN panel's guidelines on risk management for women at high risk for ovarian cancer states:
- Some research shows that hormone replacement after does not negate the reduction in breast cancer risk associated with the surgery. However, the panel cautions those considering hormone replacement to consider the limitations of the existing research when making this decision.
- Individuals who undergo hysterectomy at the time of are candidates for estrogen-only hormone replacement therapy, which has been associated with a lower risk for breast cancer compared with combined and progesterone therapy. Individuals with an intact uterus are not candidates for estrogen-only therapy due to the increased risk of endometrial cancer.
The North American Menopause Society is a professional society of experts in the field of menopause.
- In 2017, the organization released a position statement on hormone replacement therapy, which includes the following:
- Menopause symptoms and a variety of diseases are more likely to occur in women who have surgical menopause from ovary removal. These symptoms can have a major effect on quality of life and potential adverse effects on the cardiovascular system, bone, mood, sexual health and cognition, which have been shown in observational studies to be lessened by therapy.
- Unless contraindications are present, therapy for women who have removed both ovaries is indicated to reduce their risk of sexual side effects, bone loss, heart disease and decline. For women who retain their uterus, endometrial protection (progesterone) is indicated.
- Specific to women with or mutations who have removed their ovaries to lower their cancer risk:
- For women with or mutations who have not been diagnosed with breast cancer, some evidence suggests that hormone therapy after does not further increase the risk for breast cancer.
- Considerations should be made regarding the benefits of to prevent health risks caused by surgical menopause.
- Considerations should be made (based on limited data) about hormone therapy until age 52, with discussions about longer use based on the individual patient.
- In 2018, the organization released a joint position statement with the International Society for the Study of Women's Sexual Health regarding the management of genitourinary syndrome of menopause (GSM) in women who have or are at high risk for breast cancer, including the following:
- People with or at high risk for breast cancer should discuss treatment options for GSM with their healthcare providers, using a shared decision-making approach.
- For women diagnosed with breast cancer:
- Vaginal moisturizers and lubricants are recommended as initial treatment options.
- Local (vaginal) hormone treatment may be considered when nonhormonal options do not work. Local therapy should be individualized, taking into account the risk of disease recurrence and severity of vaginal symptoms.
- Intravaginal estrogens in women on tamoxifen may be less of a concern than intravaginal estrogens in women on aromatase inhibitors.
- For high-risk women without breast cancer who have undergone , vaginal hormone therapy is likely to be safe.
Updated: 08/13/2024
Questions To Ask Your Doctor
- I I had breast cancer before age 50. Should I consider genetic testing to see if I am at increased risk of ovarian cancer?
- How do I know if I am at increased risk for ovarian cancer?
- I tested negative for a mutation in despite having breast cancer before age 50. Should I be concerned about my ovarian cancer risk?
- What are my options for preventing ovarian cancer or detecting it early?
- I had my ovaries removed to reduce my risk for ovarian cancer. What steps can I take to prevent or reduce long-term complications?
- Can you refer me to a menopause expert?
Open Clinical Trials
The following studies of menopause and menopause management are for survivors and previvors.
- NCT04439370: Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women. This research studies how early menopause effects blood pressure.
- NCT03572153: A Mind-Body Intervention for Hot Flash Management. The main goal of this study is to test whether self-administered hypnosis can reduce hot flashes more effectively than self-administered white noise hypnosis over 6 weeks of home practice.
- NCT04821141: Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens. Women at increased risk for breast cancer who experience hot flashes will receive either bazedoxifene plus conjugated estrogens (similar to the drug Duavee) for 6 months or a control (no drug). Researchers will measure breast density with and needle biopsy that identifies biomarkers.
- NCT06112756: A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated with Menopause (NIRVANA). This study looks at treatment the safety and efficacy of treatment with Elinzanetant for symptoms like hot flashes caused by hormonal changes associated with menopause that can impact sleep disturbances.
Updated: 02/03/2024
Peer Support
FORCE offers many peer support programs for people with inherited mutations.
- Our Message Boards allow people to connect with others who share their situation. Once registered, you can post on the Diagnosed With Cancer board to connect with other people who have been diagnosed.
- Our Peer Navigation Program will match you with a volunteer who shares your mutation and situation.
- Our moderated, private Facebook group allows you to connect with other community members 24/7.
- Check out our virtual and in-person support meeting calendar.
- Join one of our Zoom community group meetings.
Updated: 08/06/2022
Find Experts
The following resources can help you locate an expert near you or via telehealth.
Finding menopause experts
- The Menopause Society has a tool to help you find a qualified menopause expert in your area.
Related experts
Other experts may manage some symptoms of menopause. People experiencing menopause symptoms may benefit from a consultation with the following experts:
Sexual health experts
- The Sexual Medicine Society of North America has a search tool to find experts in your area who provide sexual health care services.
- The American Association of Sexuality Educators, Counselors and Therapists maintains a tool to help people find a sexual health expert near them.
Acupuncture experts
- The National Certification Commission for Acupuncture and Oriental Medicine has a searchable directory of licensed acupuncturists.
Sleep experts
- The American Academy of Sleep Medicine maintains the public-facing website sleepeducation.org, which includes a section on finding a sleep center by location.
Bone density experts
- The Bone Health and Foundation has a searchable database for finding experts.
Other ways to find experts
- Register for the FORCE Message Boards and post on the Find a Specialist board to connect with other people who share your situation.
- National Cancer Institute (NCI)-designated comprehensive cancer centers have specialists to manage the symptoms and side effects of cancer prevention or treatment.
Updated: 09/11/2024
Related Resources
The following organizations have resources related to menopause for survivors and previvors.
- FORCE related resources:
- Information: Menopause
- XRAY category: Menopause
- FORCE video: Early menopause management for women who cannot take therapy (from 2022 conference)
- FORCE video: Menopause Management without Hormones (from 2021 conference)
- FORCE video: Early Onset Menopause Management with Hormones (from 2021 conference)
- FORCE video: Menopause Question-and-Answer Panel (from 2021 conference)
- FORCE video: Things you can do to optimize your sleep, starting tonight
- FORCE video playlist: Menopause (9 videos)
- The North Menopause Society is a professional organization devoted to promoting women's health and quality-of-life through an understanding of menopause. They certify providers who have passed an examination and maintained ongoing education related to menopause.
- The National Institutes of Health () has information about and their Osteoporosis: Research and Resources webpage has resources related to including sections specifically for people diagnosed with different types of cancer.
Updated: 09/12/2024
Who covered this study?
Science Daily
Ovarian removal to prevent ovarian cancer should not be an option for premenopausal women, research finds
This article rates 3.0 out of
5 stars
Ovarian Cancer News Today
Preventative ovary removal in premenopausal women should be discontinued, researchers warn
This article rates 3.0 out of
5 stars
CNN
Study: Removing both ovaries speeds aging in premenopausal women
This article rates 3.0 out of
5 stars